Isoproterenol Hydrochloride Injection, Solution
FDA Label NDC 70121-1604

21 label sections · Submitted to the FDA by Amneal Pharmaceuticals Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Amneal Pharmaceuticals Llc for the product Isoproterenol Hydrochloride (NDC 70121-1604). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1 indications and usage, 2.1 general considerations, 2.2 recommended dosage, 3 dosage forms and strengths, 4 contraindications, 5.1 cardiac arrhythmias and ischemia, 5.2 allergic reactions associated with sulfite, 6 adverse reactions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.